Literature DB >> 21432260

A study of the reliability of health state valuations in the Japanese EuroQol instrument.

C Hamashima1, K Yoshida.   

Abstract

OBJECTIVE: Although the Japanese EuroQol instrument was developed in 1998 by a Japanese translation team, the reliability of health state valuations of the fuller questionnaire has not yet been investigated in Japan. We carried out a pilot study to investigate the reliability of health state valuations of the Japanese EuroQol instrument.
METHODS: The survey was conducted twice with the fuller questionnaire of the Japanese EuroQol instrument in a class of preventive medicine. We analyzed test-retest reliability based on the health state valuations and calculated Cronbach's coefficient alpha of both tests. RESULTS AND
CONCLUSIONS: The mean valuations of 14 hypothetical health states and 'death' between test and retest were not significantly different by paired t-test. The reliability by calculated correlation between test and retest was 0.996 (p<0.0001). In addition, Cronbach's coefficient alpha of the first test was 0.827, and that of the second test was 0.865. Although good reliability was shown in the present study, our conclusion was limited to applications of population-based surveys because of the small number and limited subjects of the present study. Further investigations are required in the form of a population-based survey.

Keywords:  EuroQol; health related QOL; health state valuations; reliability; visual analogue scale (VAS)

Year:  2001        PMID: 21432260      PMCID: PMC2723308          DOI: 10.1007/BF02897969

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  8 in total

1.  Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

Authors:  X Badia; S Monserrat; M Roset; M Herdman
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

2.  Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.

Authors:  J A Johnson; A Ohinmaa; B Murti; H Sintonen; S J Coons
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

3.  Estimating an EQ-5D population value set: the case of Japan.

Authors:  Aki Tsuchiya; Shunya Ikeda; Naoki Ikegami; Shuzo Nishimura; Ikuro Sakai; Takashi Fukuda; Chisato Hamashima; Akinori Hisashige; Makoto Tamura
Journal:  Health Econ       Date:  2002-06       Impact factor: 3.046

4.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 5.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Test-retest reliability of health state valuations collected with the EuroQol questionnaire.

Authors:  H M van Agt; M L Essink-Bot; P F Krabbe; G J Bonsel
Journal:  Soc Sci Med       Date:  1994-12       Impact factor: 4.634

8.  Measurement and valuation of quality of life in economic appraisal of cancer treatment.

Authors:  C A Uyl-de Groot; F F Rutten; G J Bonsel
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

  8 in total
  4 in total

1.  Evaluation of the effect of urethroplasty for anterior urethral strictures by a validated disease-specific patient-reported outcome measure.

Authors:  Akio Horiguchi; Masayuki Shinchi; Kenichiro Ojima; Ayako Masunaga; Keiichi Ito; Tomohiko Asano; Eiji Takahashi; Fumihiro Kimura; Ryuichi Azuma
Journal:  World J Urol       Date:  2018-10-25       Impact factor: 4.226

2.  A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trial.

Authors:  Norio Watanabe; Toshi A Furukawa; Masaru Horikoshi; Fujika Katsuki; Tomomi Narisawa; Mie Kumachi; Yuki Oe; Issei Shinmei; Hiroko Noguchi; Kei Hamazaki; Yutaka Matsuoka
Journal:  Trials       Date:  2015-01-31       Impact factor: 2.279

3.  Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry.

Authors:  Toshifumi Fujiwara; Masakazu Kondo; Hisakata Yamada; Akihisa Haraguchi; Kenjiro Fujimura; Koji Sakuraba; Satoshi Kamura; Jun-Ichi Fukushi; Hisaaki Miyahara; Yasushi Inoue; Tomomi Tsuru; Toshihide Shuto; Seiji Yoshizawa; Eiichi Suematsu; Tomoya Miyamura; Masahiro Ayano; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Masanobu Ohishi; Akie Hirata; Shoji Tokunaga; Atsushi Takada; Daisuke Hara; Hidetoshi Tsushima; Yukio Akasaki; Satoshi Ikemura; Takuya Sueishi; Masakazu Toya; Takahide Sakuragi; Tomoko Tsutsui; Kazuhiro Kai; Shinkichi Arisumi; Yasuharu Nakashima
Journal:  Arthritis Res Ther       Date:  2022-02-22       Impact factor: 5.156

4.  Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis.

Authors:  José-Antonio López-Pina; Ana-Belén Meseguer-Henarejos; Juan-José Gascón-Cánovas; Dérlis-Julián Navarro-Villalba; Vaughn G Sinclair; Kenneth A Wallston
Journal:  Health Qual Life Outcomes       Date:  2016-09-13       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.